共 50 条
Studying harms of interventions with an equity lens in randomized trials
被引:1
|作者:
Li, Tianjing
[1
,2
]
Mayo-Wilson, Evan
[3
]
Shaughnessy, Daniel
[1
,2
]
Qureshi, Riaz
[1
,2
]
机构:
[1] Univ Colorado, Dept Ophthalmol, Anschutz Med Campus, Aurora 80045, CO USA
[2] Colorado Sch Publ Hlth, Dept Epidemiol, Aurora, CO 80045 USA
[3] Univ N Carolina, Gillings Sch Global Publ Hlth, Dept Epidemiol, Chapel Hill, NC USA
来源:
关键词:
Equity;
Health equity;
Disparity;
Harms;
Randomized trials;
VACCINE HESITANCY;
HEALTH EQUITY;
SAFETY;
D O I:
10.1186/s13063-024-08239-x
中图分类号:
R-3 [医学研究方法];
R3 [基础医学];
学科分类号:
1001 ;
摘要:
Equity and health equity are fundamental pillars in fostering a just and inclusive society. While equity underscores fairness in resource allocation and opportunity, health equity aims to eradicate avoidable health disparities among social groups. The concept of harms in interventions-undesirable consequences associated with the use of interventions-often varies across populations due to biological and social factors, necessitating a nuanced understanding. An equity lens reveals disparities in harm distribution, urging researchers and policymakers to address these differences in their decision-making processes. Furthermore, interventions, even well-intentioned ones, can inadvertently exacerbate disparities, emphasizing the need for comprehensive harm assessment. Integrating equity considerations in research practices and trial methodologies, through study design or through practices such as inclusive participant recruitment, is pivotal in advancing health equity. By prioritizing interventions that address disparities and ensuring inclusivity in research, we can foster a more equitable healthcare system.
引用
收藏
页数:5
相关论文